Background: Posttraumatic embitterment disorder (PTED) is a reaction to unjust or humiliating life events, including embitterment and impairment of mood, somatoform complaints, reduction in drive, withdrawal from social contacts, and even suicide and murder suicide. Patients have been shown to be nonresponders to many treatments. This paper gives an outline of cognitive behaviour therapy based on wisdom psychology and reports first data on treatment effects. Method: In a first pilot study on psychotherapy for PTED, a cohort of 25 PTED inpatients was treated with routine multidimensional cognitive behaviour therapy. A second consecutive cohort of 28 patients was treated with PTED-specific cognitive behaviour therapy, which is based on wisdom psychology (wisdom psychotherapy) and another 29 patients with cognitive behaviour therapy based on wisdom psychology together with additional hedonia strategies (wisdom and hedonia psychotherapy). Treatment integrity was measured with special modules of the Behaviour Therapy Competency Checklist. The outcomes were measured in all 3 groups with the SCL-90 and a global clinical rating of patients and therapists on treatment outcome. Results: There were significant and clinically meaningful reductions in the SCL score after wisdom therapy, as compared to routine treatment. In clinical ratings by therapists and patients, both specific treatments were judged as more effective than treatment as usual. Additional hedonia strategies did not lead to better treatment effects. Conclusions: The results of this pilot study suggest that wisdom psychology offers an approach to treat PTED and justify further randomized controlled outcome studies.

Keywords:
Posttraumatic embitterment disorder, Adjustment disorder, Therapeutic results, Trauma, Well-being therapy, Cognitive behaviour therapy, Wisdom therapy, Hedonia therapy, Psychotherapy outcome research, Randomized clinical trial
1.
Amiel-Lebigre F, Kovess V, Labarte S, Chevalier A: Symptom distress and frequency of life events. Soc Psychiatry Psychiatric Epidemiol 1998;33:263–268.
2.
Strain JJ, Smith GC, Hammer JS, McKenzie DP, Blumenfield M, Muskin P, Newstadt G, Wallack J, Wilner A, Schleifer SS: Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry 1998;20:139–149.
3.
Despland JN, Monod L, Ferrero F: Clinical relevance of adjustment disorder in DSM-III-R and DSM-IV. Compr Psychiatry 1995;36:454–460.
4.
O’Brien LS: Traumatic Events and Mental Health. Cambridge, Cambridge University Press, 1998.
5.
Fischer G, Riedesser P: Lehrbuch der Psychotraumatologie. München, Reinhardt, 1999.
6.
Fava GA, Sonino N: Psychosomatic medicine. A name to keep. Psychother Psychosom 2010;79:1–3.
7.
Paykel ES: Stress and affective disorders in humans. Semin Clin Neuropsychiatry 2001;6:4–11.
8.
Orth U, Maercker AJ: Posttraumatic anger in crime victims: directed at the perpetrator and at the self. J Trauma Stress 2009;22:158–161.
9.
Maercker A, Forstmeier S, Enzler A, Krüsi G, Hörler E, Maier C, Ehlert U: Adjustment disorders, posttraumatic stress disorder, and depressive disorders in old age: findings from a community survey. Compr Psychiatry 2008;49:113–120.
10.
Dobricki M, Maercker A: (Post-traumatic) embitterment disorder: a critical evaluation of its stressor criterion and a proposed revised classification. Nord J Psychiatry 2010;64:147–152.
11.
Linden M: The posttraumatic embitterment disorder. Psychother Psychosom 2003;72:195–202.
12.
Linden M, Rotter M, Baumann K, Lieberei B: Posttraumatic Embitterment Disorder. Bern, Huber, 2007.
13.
Sensky T: Chronic embitterment and organizational justice. Psychother Psychosom 2010;79:65–72.
14.
Linden M, Maercker A: Embitterment. Vienna, Springer, 2010.
15.
Baltes PB, Smith J: Weisheit und Weisheitsentwicklung: Prolegomena zu einer psychologischen Weisheitstheorie. Ztschr Entwicklungspsychol Päd Psychol 1990;22:95–135.
16.
Staudinger UM, Lopez D, Baltes PB: The psychometric location of wisdom-related performance: intelligence, personality, and more? Personality Soc Psychol Bull 1997;23:1200–1214.
17.
Sternberg RJ: A balance theory of wisdom. Rev Gen Psychol 1998;2:347–365.
18.
Böhmig-Krumhaar SA, Staudinger UM, Baltes PB: Mehr Toleranz tut Not: Lässt sich wert-relativierendes Wissen und Urteilen mit Hilfe einer wissensaktivierenden Gedächtnistrategie verbessern? Ztschr Entwicklungspsychol Päd Psychol 2002;34:30–43.
19.
Mickler C, Staudinger UM: Personal wisdom: validation and age-related differences of a performance measure. Psychol Aging 2008;23:787–799.
20.
Meeks TW, Jeste DV: Neurobiology of wisdom: a literature overview. Arch Gen Psychiatry 2009;66:355–365.
21.
Lutz R, Koppenhöfer E: Kleine Schule des Geniessens; in Lutz R (ed): Genuss und Geniessen. Weinheim, Beltz, 1983.
22.
Lutz R, Mark N, Bartmann U, Hoch E, Stark FM (eds): Beiträge zur Euthymen Therapie. Freiburg, Lambertus, 1999.
23.
Linden M, Weig W: Salutotherapie. Köln, Deutscher Ärzteverlag, 2009.
24.
Fava GA, Ruini C: Development and characteristics of a well-being enhancing psychotherapeutic strategy: well-being therapy. J Behav Ther Exp Psychiatry 2003;34:45–63.
25.
Ruini C, Fava GA: Well-Being Therapy for Generalized Anxiety Disorder. J Clin Psychol 2009;65:510–519.
26.
Schippan B, Baumann K, Linden M: Weisheitstherapie: Kognitive Therapie der Posttraumatischen Verbitterungsstörung. Verhaltenstherapie 2004;14:284–293.
27.
Baumann K, Linden M: Weisheitskompetenzen und Weisheitstherapie. Lengerich, Pabst, 2008.
28.
Linden M, Baumann K, Rotter M, Lieberei B: Diagnostic Criteria and the Standardized Diagnostic Interview for Posttraumatic Embitterment Disorder (PTED). Int J Psychiatry Clin Pract 2008;12:93–96.
29.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavas J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22–33.
30.
Derogatis LR: The Symptom Checklist-90-revised. Minneapolis, NCS Assessments, 1992.
31.
Linden M, Langhoff C, Rotter M: Defini- tion, operationalization, and quality assurance of psychotherapy: an investigation with the Behavior Therapy-Competence-Checklist (BTCC). Psychiatria Danubina 2007;19:308–316.
32.
Glogower FD, Fremouw WJ, McCrosky JC: A component analysis of cognitive restructuring. Cogn Ther Res 1978;2:209–223.
33.
Kirmayer LJ: Resistance, reactance, and reluctance to change: a cognitive attributional approach to strategic interventions. J Cogn Psychother 1990;4:83–104.
34.
Al-Mabuk RH, Dedrick CVL, Vanderath KM: Attribution retraining in forgiveness therapy. J Family Psychother 1998;9:11–30.
35.
Wells A, Sembi S: Metacognitive therapy for PTSD: a core treatment manual. Cogn Behav Pract 2004;11:365–377.
36.
Coelho HF, Canter PH, Ernst E: Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. J Consult Clin Psychol 2007;75:1000–1005.
37.
Orsillo SM, Batten SV: Acceptance and commitment therapy in the treatment of posttraumatic stress disorder. Behav Modif 2005;29:95–129.
38.
Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R: The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 2009;78:275–284.
39.
Rutherford BR, Sneed JR, Roose SP: Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 2009;78:172–181.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.